Technical Data
V2100-03
Varicella Zoster Virus, Glycoprotein B (VZV Glycoprotein B, VZV gB, gp140/62, gpII, Human Herpes Virus 3, Human Herpes virus 3, HHV3 gB, ORF31)
Description:
Varicella Zoster Virus (VZV) is a member of the human herpes virus family which causes two distinct clinical manifestations: childhood chickenpox (Varicella) and shingles (Zoster). Varicella is the outcome of the primary infection with VZV. Whereas, Zoster is the result of VZV reactivation from latently infected sensory ganglia which occurs predominantly in aging and immunosuppressed individuals.

Applications:
Suitable for use in Immunofluorescence and ELISA. Other applications not tested.

Recommended Dilutions:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
MabIgG19F460Affinity Purified
SizeStorageShippingSourceHost
100ug-20CBlue IceMouse
Concentration:
~1mg/ml
Immunogen:
VZV Glycoprotein B.
Purity:
Purified by affinity chromatography.
Form
Supplied as a liquid in PBS, pH 7.4.
Specificity:
Recognizes VZV Glycoprotein B. Recognizes a confirmational epitope on the protein and therefore cant be used in experiments requiring protein denaturation.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Jacquet, A., et al., Virus Res. 53(2): 197-207 (1998).